Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Scorpio Tankers
STNG
$3.82B
| $3.45M | ﹤0.01% |
269,643
+126,220
| +88% | +$2.29M |
|
3002
LPL Financial
LPLA
$28.2B
| $3.45M | ﹤0.01% |
43,977
-76,252
| -63% | -$5.1M |
|
|
SHI
3003
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $3.44M | ﹤0.01% |
144,006
+116,057
| +415% | +$3M |
|
3004
Schwab Fundamental International Small Company Index ETF
FNDC
$3.13B
| $3.43M | ﹤0.01% |
124,646
-25,947
| -17% | -$680K |
|
3005
Kulicke & Soffa
KLIC
$4.79B
| $3.42M | ﹤0.01% |
164,420
-10,262
| -6% | -$232K |
|
|
PEO
3006
Adams Natural Resources Fund
PEO
$724M
| $3.42M | ﹤0.01% |
312,683
-5,887
| -2% | -$60.3K |
|
|
ECOL
3007
DELISTED
US Ecology, Inc.
ECOL
| $3.42M | ﹤0.01% |
100,827
+201
| +0.2% | +$6.55K |
|
3008
Preferred Bank
PFBC
$1.25B
| $3.41M | ﹤0.01% |
79,591
+1,960
| +3% | +$72.1K |
|
3009
Precigen
PGEN
$2.44B
| $3.41M | ﹤0.01% |
682,634
+22,070
| +3% | +$75.1K |
|
3010
Bright Horizons
BFAM
$3.88B
| $3.4M | ﹤0.01% |
29,062
-157,343
| -84% | -$18M |
|
|
EB
3011
DELISTED
Eventbrite
EB
| $3.4M | ﹤0.01% |
396,761
+35,943
| +10% | +$317K |
|
3012
Karyopharm Therapeutics
KPTI
$43.7M
| $3.4M | ﹤0.01% |
11,961
+7,989
| +201% | +$2.36M |
|
3013
State Street SPDR S&P 1500 Momentum Tilt ETF
MMTM
$163M
| $3.4M | ﹤0.01% |
25,313
-1,458
| -5% | -$184K |
|
3014
iShares MSCI Philippines ETF
EPHE
$144M
| $3.4M | ﹤0.01% |
126,220
+3,315
| +3% | +$83.9K |
|
3015
Towne Bank
TOWN
$3.46B
| $3.39M | ﹤0.01% |
179,973
+48,458
| +37% | +$899K |
|
3016
Invesco Pharmaceuticals ETF
PJP
$478M
| $3.38M | ﹤0.01% |
52,252
+2,646
| +5% | +$164K |
|
|
AKRO
3017
DELISTED
Akero Therapeutics
AKRO
| $3.38M | ﹤0.01% |
135,590
+134,315
| +10,535% | +$3.07M |
|
|
GLCN
3018
DELISTED
VanEck China Growth Leaders ETF
GLCN
| $3.38M | ﹤0.01% |
83,965
-11,277
| -12% | -$420K |
|
3019
Cue Biopharma
CUE
$116M
| $3.38M | ﹤0.01% |
4,590
+3,283
| +251% | +$2.38M |
|
3020
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$250M
| $3.38M | ﹤0.01% |
187,444
-27,894
| -13% | -$459K |
|
|
PFD
3021
Flaherty & Crumrine Preferred and Income Fund
PFD
$147M
| $3.37M | ﹤0.01% |
232,292
+69,374
| +43% | +$974K |
|
3022
MGE Energy Inc
MGEE
$3.02B
| $3.37M | ﹤0.01% |
52,188
+2,984
| +6% | +$195K |
|
|
IGI
3023
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.4M
| $3.36M | ﹤0.01% |
155,415
+10,972
| +8% | +$230K |
|
|
GPMT
3024
Granite Point Mortgage Trust
GPMT
$61.3M
| $3.36M | ﹤0.01% |
467,476
+46,285
| +11% | +$251K |
|
3025
Encompass Health
EHC
$12.4B
| $3.35M | ﹤0.01% |
68,072
-93
| -0.1% | -$5.02K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.